Next Article in Journal
Pre-Existing and Acquired Resistance to PARP Inhibitor-Induced Synthetic Lethality
Next Article in Special Issue
MicroRNA, mRNA, and Proteomics Biomarkers and Therapeutic Targets for Improving Lung Cancer Treatment Outcomes
Previous Article in Journal
A Clinical Guide to Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in Neuroendocrine Tumor Patients
Previous Article in Special Issue
Survival Benefit of Adjuvant Chemotherapy in Pulmonary Carcinoid Tumors
 
 
Article

Article Versions Notes

Cancers 2022, 14(23), 5791; https://doi.org/10.3390/cancers14235791
Action Date Notes Link
article pdf uploaded. 24 November 2022 16:16 CET Version of Record https://www.mdpi.com/2072-6694/14/23/5791/pdf-vor
article supplementary file uploaded. 24 November 2022 16:16 CET - https://www.mdpi.com/2072-6694/14/23/5791#supplementary
article xml file uploaded 25 November 2022 11:32 CET Original file -
article xml uploaded. 25 November 2022 11:32 CET Update https://www.mdpi.com/2072-6694/14/23/5791/xml
article pdf uploaded. 25 November 2022 11:33 CET Updated version of record https://www.mdpi.com/2072-6694/14/23/5791/pdf
article html file updated 25 November 2022 11:34 CET Original file -
article html file updated 1 March 2023 00:48 CET Update -
article html file updated 3 March 2023 22:44 CET Update https://www.mdpi.com/2072-6694/14/23/5791/html
Back to TopTop